Rate of emergency department visits decreased 80 and 82 percent in 2020 versus previous two years for week starting March 22
Neurologic Complications of COVID-19 Described
Most common neurologic findings in patients hospitalized for COVID-19 include altered mental status, fatigue, headache, stroke
FDA Authorizes First OTC COVID-19 Home Test Collection Kit
Last week, the agency also authorized an at-home test collection kit for COVID-19 and flu, available by prescription
Kidney Disease Leading Risk Factor for COVID-19 Hospitalization
COVID-19 patients with end-stage renal disease 11 times more likely to be hospitalized versus patients with no kidney disease
Deaths Up During Pandemic for Those With Rare Autoimmune Disorders
Individuals with rare autoimmune rheumatic diseases have prominently increased risk for death versus general population
Risk Factors for Severe COVID-19 Up in Cancer Survivors
Cancer survivors also have increased risk for influenza hospitalization/death compared with cancer-free controls
FDA Advisory Committee OKs Pfizer-BioNTech COVID-19 Vaccine
Committee recommends emergency use authorization of the vaccine; vaccine to be distributed within 24 hours of EUA
American Indians/Alaska Natives Have Elevated COVID-19 Mortality
Disparity between AI/AN and White individuals largest for those aged 20 to 49 years
Live-Attenuated Virus Vaccine Development ‘is the Right Approach'
A vaccine biotech firm based in Massachusetts points to the proven science of live-attenuated viruses in vaccine development as key to the company's commitment to the development platform.
A live-attenuated virus is a weakened (attenuated) virus that is able to multiply within the host to a limited extent and engineered to be unable to cause any disease.
Live-Attenuated Virus Vaccine Development 'is the Right Approach'
A vaccine biotech firm based in Massachusetts points to the proven science of live-attenuated viruses in vaccine development as key to the company's commitment to the development platform.
A live-attenuated virus is a weakened (attenuated) virus that is able to multiply within the host to a limited extent and engineered to be unable to cause any disease.